Back

Development of a replication-defective MPXV platform for fundamental and therapeutic research

Chen, J.; Hu, L.; Shi, N.; Tian, J.; Zhang, Y.; Tian, S.; Cao, X.; Ha, Z.; Cai, Q.; Lu, Y.; Smith, G. L.; Xie, Y.; Lu, H.; Zhang, P.; Zhang, R.

2025-06-23 microbiology
10.1101/2025.06.21.660854 bioRxiv
Show abstract

The recent global outbreaks of mpox highlight the urgent need for both fundamental research and antiviral development. However, studying monkeypox virus (MPXV), with its large and complex genome, remains challenging due to the requirement for high-containment facilities. Here, we describe a novel strategy for de novo assembly of MPXV clade IIb genomes in bacterial artificial chromosomes using transformation-associated recombination cloning. Leveraging CRISPR-Cas9 and Lambda Red recombination, we engineered replication-defective MPXV particles with dual deletions of OPG96 (M2R) and OPG158 (A32.5L)--genes essential for virion assembly, that are capable of recapitulating key stages of the viral life cycle. Our work demonstrates the utility of replication-defective MPXV particles as a reliable platform for high-throughput antiviral discovery, offering significant advantages for both fundamental virology studies and therapeutic development against orthopoxviruses.

Matching journals

The top 5 journals account for 50% of the predicted probability mass.

50% of probability mass above

"Similar papers" are the closest papers from that journal in the model's embedding space. They show what the match is built on, but the ranking comes mostly from a classifier over the whole training set, not from these examples alone.